Mumbai, India's pharmaceutical hotspot, hosts several major players in the Carboplatin Active Pharmaceutical Ingredient (API) production landscape. A number of firms , including Cipla, are known to manufacture Carboplatin API (CAS No: 41575-94-4) complying with stringent quality standards. These